loader2
Partner With Us NRI

Ajanta Pharma Ltd share Price Today

Company details

2,370.10
2,458.95
1,246.75
2,540.00
6M Return 26.78%
1Y Return 85.79%
Mkt Cap.(Cr) 29,935.27
Volume 1,35,221
Div Yield 2.15%
OI
-
OI Chg %
-
Volume 1,35,221
NSE

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started

Pharmaceuticals company Ajanta Pharma announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Revenue from operations at Rs 1,054 crore against Rs 882 crore; up 20%.
  • EBITDA at Rs 278 crore against Rs 149 crore; up 86%; EBITDA at 26%.
  • Profit after tax at Rs 203 crore against Rs 122 crore; up 66%; PAT at 19%.

FY24 Financial Highlights:

  • Revenue from operations at Rs 4,209 crore against Rs 3,743 crore; up 12%.
  • EBITDA at Rs 1,172 crore against Rs 783 crore; up 50%; EBITDA at 28%.
  • Profit after tax at Rs 816 crore against Rs 588 crore; up 39%; PAT at 19%.
  • Cashflow from operations (CFO) was Rs 785 crore, EBITDA to CFO conversion of 67%.
  • Free cashflow (FCF) was Rs 637 crore, FCF to PAT conversion of 78%.

Result PDF

View Other Company Results

Ajanta Pharma Ltd shares SWOT Analysis

Strengths (7)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Weakness (2)

  • Decline in Net Profit (QoQ)
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income
Discover More

Resistance and support

R1 2,434.2
R2 2,491.0
R3 2,523.1
Pivot

2,402.15

S1 2,345.4
S2 2,313.3
S3 2,256.5
EMA SMA
2,264.4
2,197.5
2,122.7
1,964.7
2,215.2
2,173.8
2,152.7
1,963.4
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
SOCIETE GENERALE Block Purchase 2024-01-25 2195.5 125617 BSE
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND Block Purchase 2024-01-25 2195.5 47901 BSE
MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND Block Purchase 2024-01-25 2195.5 2685 BSE
Discover More
Name Category Shares
Rajesh M Agrawal, trustee Rajesh Agrawal Trust PROMOTER 14.48%
Yogesh M Agrawal, trustee Yogesh Agrawal Trust PROMOTER 14.48%
Ravi P Agrawal, trustee Ravi Agrawal Trust PROMOTER 13.01%
Aayush M Agrawal, trustee Aayush Agrawal Trust PROMOTER 11.31%
Ganga Exports being represented by Yogesh Agrawal, Rajesh Agrawal & Ravi Agrawal PROMOTER 2.68%
Gabs Investments Pvt Ltd PROMOTER 10%

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Ajanta Pharma Ltd Stocks COMPARISON

Financials( ₹ in Cr) Ajanta Pharma Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 2,377.40 1,506.55 1,339.55 3,793.50 982.15
% Change -1.34 0.80 -1.42 0.09 1.44
Mcap ₹ Cr 29,935.27 3,61,471.81 1,08,150.85 1,00,705.67 98,827.27
Revenue TTM ₹ Cr 3,742.64 43,885.68 22,753.12 7,767.51 17,237.40
Net Profit TTM ₹ Cr 587.98 8,560.84 2,835.49 1,823.38 1,997.30
PE TTM 36.65 38.52 25.40 72.78 29.65
1 Year Return 85.79 57.35 42.63 12.13 87.09
ROCE 22.21 16.79 17.79 19.30 16.25
ROE 17.68 16.46 12.82 14.89 14.05
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 3,387.99 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 40,292.52 -39,101.37
LAST 3M 97,195.39 -16,897.62
LAST 6M 1,59,485.99 61,690.63
LAST 12M 2,49,857.63 1,46,087.29
Ajanta Pharma Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 08, 2024 l NSE Announcement

Ajanta Pharma Limited - Updates

May 06, 2024 l NSE Announcement

DISCOVER MORE
Date Action Type Ratio
Feb 08, 2024 Dividend 1300
Aug 04, 2023 Dividend 750
Aug 04, 2023 Dividend 500
DISCOVER MORE

Ajanta Pharma Ltd Information

Stock PE (TTM)
36.65
Promoter Holding
66.21%
Book Value
283.3043
ROCE
22.21%
ROE
17.68%
Registered Address

Ajanta House, Charkop Kandivli (W), Mumbai, Maharashtra, 400067

Tel : 91-22-66061000/1204/1203
Email : info:ajantapharma.com; investorgrievance:ajantapha
Website : http://www.ajantapharma.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 532331
NSE Code : AJANTPHARM
Book Closure Date (Month) :
BSE Group : A
ISIN : INE031B01049

FAQ’s on Ajanta Pharma Ltd Shares

You can buy Ajanta Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Ajanta Pharma Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 10, 2024 03:58 PM the closing price of Ajanta Pharma Ltd was Rs.2,377.40.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 10, 2024 03:58 PM, the market cap of Ajanta Pharma Ltd stood at Rs. 29,935.27.

The latest PE ratio of Ajanta Pharma Ltd as of May 10, 2024 03:58 PM is 36.65

The latest PB ratio of Ajanta Pharma Ltd as of May 10, 2024 03:58 PM is 0.12

The 52-week high of Ajanta Pharma Ltd share price is Rs. 2,540.00 while the 52-week low is Rs. 1,246.75

According to analyst recommendations, Ajanta Pharma Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number
Get Started
Open a Trading Account